China and US-headquartered biomedical firm Brii Bio has raised US$260 million from Sequoia Capital, Yunfeng Capital and others.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
